Literature DB >> 19282561

Oncologists should measure life, not death: a newer perspective of cancer statistics.

A Srivastava1, A Sood.   

Abstract

We discuss why we should measure parameters of 'life' and not 'death' in choosing a therapy for cancer and what are the flaws and difficulties in measuring cancer specific deaths. We then submit those parameters which can be measured with high precision and validity in cancer patients and so should be recorded to guide us in deciding the best therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19282561     DOI: 10.4103/0019-509x.48590

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  1 in total

1.  Most breast cancer screening trials have a flawed design.

Authors:  Nishant Gurnani; Anurag Srivastava
Journal:  Indian J Surg       Date:  2011-10-25       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.